Skip to main content
. 2021 Sep 11;40:101124. doi: 10.1016/j.eclinm.2021.101124

Fig. 5.

Fig. 5

Changes in Terminal to Vellus Hair Ratio from Baseline Over 24 Weeks. Treatment group ALRV5XR increased statistically significantly to the placebo group for both (a) Absolute Change in Terminal to Vellus Hair Ratio: 0·5 compared to placebo with OR of 81·0 [95% CI: 0·2–0·9; (p = 0·0097)] and (b) Per Cent Change in Terminal to Vellus Hair Ratio: 33·0% with an OR of 81·0 [95% CI: 12·5%–53·4%; (p = 0·0033)]. Linear regressions are shown as lines with 95% confidence intervals shown in grey.